Market Capitalization (Millions $) |
213 |
Shares
Outstanding (Millions) |
21 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
2 |
Cash Flow (TTM) (Millions $) |
2 |
Capital Exp. (TTM) (Millions $) |
0 |
Da32 Life Science Tech Acquisition Corp
Da32 Life Science Tech Acquisition Corp is a special purpose acquisition company (SPAC) focused on the life science technology sector. The company was formed with the purpose of acquiring or merging with existing businesses in the life science tech industry to provide capital and support for their growth and expansion. Da32 Life Science Tech Acquisition Corp aims to identify and invest in high-potential companies that are developing innovative solutions in areas such as medical diagnostics, biotechnology, pharmaceuticals, and digital health technologies.
Company Address: 345 Park Avenue, 12th Floor New York 10010 NY
Company Phone Number: 551-1600 Stock Exchange / Ticker: NASDAQ DALS
DALS is expected to report next financial results on March 28, 2024. |
|
|